MK-677 (Ibutamoren) – Comprehensive Research Overview (2026)
MK-677 (Ibutamoren) is an orally active, non-peptide ghrelin receptor (GHS-R1a) agonist and growth hormone secretagogue. Unlike injectable peptides, MK-677 is taken orally and provides sustained elevation of growth hormone (GH) and IGF-1 levels. It is one of the most widely researched compounds for body composition, muscle growth, fat loss, recovery, and anti-aging protocols.
→ View MK-677 (for laboratory research use only)
Chemical Structure and Properties
- Chemical Name: 2-amino-2-methyl-N-[1-(methylsulfonyl)spiro[indoline-3,4’-piperidin]-1’-yl]-N’-[2-(1-methylethylsulfonyl)phenyl]propanediamide
- Molecular Weight: ≈624 Da
- Form: Oral capsule or tablet
- Key Feature: Orally bioavailable with a long half-life (~24 hours), enabling once-daily dosing
Mechanism of Action
MK-677 mimics ghrelin by binding to the GHS-R1a receptor on pituitary somatotrophs and hypothalamic neurons:
- Stimulates pulsatile GH release and sustained IGF-1 elevation.
- Promotes anabolic effects across muscle, adipose, bone, and liver.
- Engages natural somatostatin-mediated negative feedback with prolonged use.
- Stimulates appetite via hypothalamic ghrelin pathways.
Clinical Evidence and Research Findings
MK-677 has been evaluated in multiple clinical trials demonstrating consistent GH and IGF-1 elevation, improvements in lean body mass, bone mineral density, and sleep quality. It has been studied in elderly populations, GH-deficient patients, and healthy adults. While not FDA-approved for body composition, it has one of the strongest clinical data sets among research peptides.
→ Interested in researching MK-677? View Product Options
Benefits (Research & Clinical Observations)
- Increased lean muscle mass and strength
- Enhanced fat loss and improved body composition
- Improved sleep quality (especially deep sleep)
- Better bone mineral density
- Support for overall vitality and anti-aging research
- Convenient once-daily oral dosing
Typical Dosing Protocols (Off-Label / Compounded)
- Common protocols: 10–25 mg once daily (typically at bedtime)
- Many users start at 10–12.5 mg and titrate based on tolerance
- Cycles: 8–16 weeks on, followed by 4–8 weeks off
- Best taken at night to align with natural GH pulses and minimize hunger during the day
Safety Profile and Side Effects
MK-677 is generally well-tolerated at research doses.
Common side effects:
- Increased appetite and hunger
- Mild water retention
- Possible transient increase in fasting glucose or insulin resistance with chronic use
- Lethargy or fatigue (especially at higher doses)
Monitoring recommended: IGF-1, fasting glucose, HbA1c, and insulin sensitivity with prolonged use. Contraindicated in active cancer or uncontrolled diabetes.
MK-677 vs CJC-1295/Ipamorelin vs Sermorelin – Quick Comparison
| Aspect | MK-677 | CJC-1295 + Ipamorelin | Sermorelin |
|---|---|---|---|
| Administration | Oral | Injectable | Injectable |
| GH Pattern | Sustained elevation | Sharp pulses | Pulsatile |
| Dosing Frequency | Once daily | 1–3× daily | Daily |
| Appetite Effect | Strong | Minimal (Ipamorelin) | Minimal |
| FDA Status | Not approved | Not approved | Not approved |
FAQ – Frequently Asked Questions
Is MK-677 a steroid? No. It is a non-steroidal ghrelin mimetic that stimulates natural GH production.
Can MK-677 be used alone? Yes. Its oral convenience makes it popular as a standalone compound.
How long until results are seen? IGF-1 rises within days; noticeable improvements in sleep, recovery, and body composition typically appear within 2–6 weeks.
Does MK-677 suppress natural GH production? It stimulates natural production but may engage somatostatin feedback with prolonged use.
Is MK-677 FDA approved? No. It is available only as a research chemical or through compounding pharmacies under physician supervision.
Summary
MK-677 is a uniquely convenient oral growth hormone secretagogue with one of the strongest clinical data sets in the research peptide space. Its once-daily dosing, consistent IGF-1 elevation, and broad anabolic effects make it a popular starting point for GH axis research. As with all compounds in this library, MK-677 is not an approved drug and should only be considered under qualified medical supervision with appropriate lab monitoring.
For Laboratory Research Use View MK-677 →
Disclaimer This overview is strictly educational and based on publicly available scientific literature and regulatory information as of April 2026. It does not constitute medical advice, endorsement, or encouragement of use. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.